Two Recent Studies Question Xarelto’s Safety
Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has continued to come under scrutiny by parts of the medical community. Initially, the drug was approved to help reduce the risk of blood clots in patients who had undergone knee or hip replacement. Later, Xarelto was approved to help patients with deep vein thrombosis (DVT) and pulmonary embolism. Unfortunately, hundreds of patients who have taken the drug have experience negative side effects, including uncontrollable internal bleeding that has no antidote.
One recent study, led by doctors Judy H. Hun and John C. Hwang, linked usage of the drug to an increased incidence of spontaneous vitreous hemorrhage, or eye bleeding, and noted that it was most notable when patients switched from one blood thinner to Xarelto. A second study compared the safety of Xarelto and Pradaxa to warfarin, the more traditional anticoagulant in the market today. Their study suggested a link between Xarelto and Pradaxa usage to a 50% increased risk of gastrointestinal bleeding. There are more than 500 Xarelto-related lawsuits pending in consolidated state and federal courts.
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at firstname.lastname@example.org.